Q92793 (CBP_HUMAN) Homo sapiens (Human)

CREB-binding protein UniProtKBAFDB90v4InterProSTRINGInteractive Modelling

2442 aa; Sequence (Fasta) ; (Isoform 2)

Available Structures

133 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Cryo-EM structure of the CBP catalytic core bound to the H4K12acK16ac nucleosome, class 1
8hal
 Heteromer
P04908; P06899; P62805; P68431; 		1086-1701
Assess
Cryo-EM structure of the CBP catalytic core bound to the H4K12acK16ac nucleosome, class 3
8han
 Heteromer
P04908; P06899; P62805; P68431; 		1088-1700
Assess
Cryo-EM structure of the CBP catalytic core bound to the H4K12acK16ac nucleosome, class 2
8ham
 Heteromer
P04908; P06899; P62805; P68431; 		1087-1698
Assess
Crystal Structure of the Bromodomain-PHD Finger Module of Human Transcriptional Co-Activator CBP in…
4n4f
 Heteromer
P62805; 		1081-1312
2×ZN;
Assess
Crystal Structure of the Bromodomain-PHD Finger Module of Human Transcriptional Co-Activator CBP in…
4n3w
 Heteromer
P62805; 		1082-1312
2×ZN;
Assess
NMR Structure of CBP Bromodomain in complex with p53 peptide
1jsp
 Heteromer
P04637; 		1081-1197
Assess
Complex Structures of CBP Bromodomain with H4 ack20 Peptide
2rny
 Heteromer
P62805; 		1081-1197
Assess
Crystal structure of CBP Bromodomain with H3K56ac peptide
5gh9
 Heteromer
P68431; 		1084-1196
Assess
NMR structure of CBP TAZ2 and adenoviral E1A complex
2kje
 Heteromer
P03255; 		1763-1854
3×ZN;
Assess
Allosteric communication in the KIX domain proceeds through dynamic re-packing of the hydrophobic c…
2lxs
 Heteromer
Q03164; 		587-673
Assess
Allosteric communication in the KIX domain proceeds through dynamic re-packing of the hydrophobic c…
2lxt
 Heteromer
P16220; Q03164; 		587-673
Assess
The structure of E-protein activation domain 1 bound to the KIX domain of CBP/p300 elucidates leuke…
2kwf
 Heteromer
P15884; 		587-673
Assess
Crystal structure of the KIX domain of CBP in complex with a MLL/c-Myb chimera
5svh
 Heteromer
P01103; Q03164; 		589-673
2×GOL; 7×CL;
Assess
cryo-EM structure of MBP-KIX-apoferritin complex with peptide 7
7tbh
 Heteromer
P09528; P16220; 		597-668
Assess
Crystal structure of complex between nuclear coactivator binding domain of CBP and [1040-1086]ACTR …
6sqc
 Heteromer
P0AEX9; Q9Y6Q9; 		2046-2112
1×GLC; 1×EDO; 2×ZN;
Assess
Docked structure between SUMO1 and ZZ-domain from CBP
2n1a
 Heteromer
P63165; 		1699-1751
2×ZN;
Assess
Structure and dynamics conspire in the evolution of affinity between intrinsically disordered prote…
6es7
 Heteromer
Q9Y6Q9; 		2061-2109
Assess
Structure and dynamics conspire in the evolution of affinity between intrinsically disordered prote…
6es6
 Heteromer
2061-2108
Assess
IRF3-CBP complex
1zoq
 Heteromer
Q14653; 		2065-2111
Assess
Structure and dynamics conspire in the evolution of affinity between intrinsically disordered prote…
6es5
 Heteromer
2061-2105
Assess
Complex of IRF-3 with CBP
5jem
 Heteromer
Q14653; 		2065-2106
Assess
Crystal structure of mouse phosphorylated IRF-3 bound to CBP
7jfm
 Heteromer
P70671; 		2066-2106
Assess
Crystal structure of human phosphorylated IRF-3 bound to CBP
7jfl
 Heteromer
Q14653; 		2066-2104
Assess
Crystal structure of SMAD2 in complex with CBP
6m64
 Heteromer
Q15796; 		1951-1973
Assess
Crystal structure of SMAD2 in complex with wild-type CBP
7co1
 Heteromer
Q15796; 		1951-1970
Assess
Crystal structure of PPAR gamma in complex with CREB-binding protein and agonist GW1929
7rle
 Heteromer
P37231; 		60-77
2×EDK;
Assess
Crystal Structure of a new rexinoid bound to the RXRalpha ligand binding doamin in the RXRalpha/PPA…
1rdt
 Heteromer
P19793; P37231; Q15788; 		68-74
1×L79; 1×570;
Assess
cryo-EM structure of MBP-KIX-apoferritin
7tb3
homo-24-mer597-668
Assess
Crystal structure of CBP bromodomain liganded with Y08284
7xne
homo-2-mer1083-1197
2×GHF; 1×GOL;
Assess
Crystal structure of the CBP bromodomain in complex with small molecule LC-CPin7
6lqx
homo-2-mer1082-1196
1×EOO; 4×NA;
Assess
Crystal structure of CBP bromodomain liganded with Y08092(31g)
7xng
homo-2-mer1084-1196
2×GI5; 1×GOL; 1×PEG;
Assess
CBP in complex with Cpd637 ((R)-4-methyl-6-(1-methyl-3-(1-methyl-1H-pyrazol-4-yl)-1H-indazol-5-yl)-…
5i8g
monomer1081-1312
3×ZN; 1×69E; 1×B3P; 5×EDO; 1×NA; 2×PEG;
Assess
CBP in complex with Cpd23 ((R)-6-(3-(benzyloxy)phenyl)-4-methyl-1,3,4,5-tetrahydro-2H-benzo[b][1,4]…
5i8b
monomer1081-1312
3×ZN; 1×69F; 1×B3P; 5×EDO; 1×NA; 1×PEG;
Assess
CREBBP bromodomain in complex with Cpd 30 (1-(3-(3-(1-methyl-1H-pyrazol-4-yl)isoquinolin-8-yl)-1-(t…
6alb
monomer1081-1312
3×ZN; 1×B3P; 1×BKJ;
Assess
Crystal structure of the bromodomain of human CREBBP in complex with a benzoxazepine compound
5j0d
monomer1081-1197
1×6F9; 3×EDO;
Assess
Crystal structure of the bromodomain of human CREBBP in complex with UN32
5ep7
monomer1081-1197
1×5QR;
Assess
CBP-BrD complexed with NEO2734
7wx2
monomer1081-1197
1×7OW;
Assess
Crystal structure of CREBBP bromodomain complexd with US46C
5mme
monomer1081-1197
1×8Q6;
Assess
Crystal structure of CREBBP bromodomain complexed with CBP019
5mqk
monomer1081-1197
1×QPR;
Assess
Bromodomain of CBP liganded with iCBP6
8fxe
monomer1081-1197
1×YID; 2×EDO;
Assess
Crystal Structure Analysis of the CBP
5xxh
monomer1081-1197
1×E0D; 1×EDO; 1×MG;
Assess
Crystal structure of the bromodomain of human CREBBP in complex with a hydroquinazolin ligand
3p1f
monomer1081-1197
3×EDO; 1×K; 1×3PF;
Assess
Crystal structure of the bromodomain of human CREBBP bound to the inhibitor XDM3c
5lpl
monomer1081-1197
1×71X;
Assess
Crystal structure of the bromodomain of human CREBBP in complex with UO37D
5h85
monomer1081-1197
1×5XS;
Assess
Crystal structure of the human bromodomain of CREBBP bound to the inhibitor XDM-CBP
5nu3
monomer1081-1197
1×99E; 4×BU3; 1×SO4;
Assess
Structure of bromodomain of CREBBP with a pyrazolo[4,3-c]pyridin fragment
5tb6
monomer1081-1197
1×77X; 1×EDO;
Assess
Crystal Structure of the bromdomain of human CREBBP in complex with a 3,5-dimethylisoxazol ligand
3svh
monomer1081-1197
2×KRG; 1×EDO;
Assess
Crystal structure of CBP bromodomain liganded with Y08175
7xij
monomer1081-1197
1×EJ3; 1×DMS; 2×GOL;
Assess
Crystal structure of CREBBP bromodomain complexd with PA10
6frf
monomer1081-1197
1×E3T;
Assess
BROMO domain of CREB binding protein
4whu
monomer1081-1197
1×3OT;
Assess
Crystal structure of the CREBBP bromodomain in complex with a benzo-diazepine ligand
6yij
monomer1081-1197
1×OSN;
Assess
Solution NMR structures of CBP bromodomain with small molecule j28
2l84
monomer1081-1197
1×J28;
Assess
Solution NMR structures of CBP bromodomain with small molecule of HBS
2l85
monomer1081-1197
1×L85;
Assess
Target Structure-Based Discovery of Small Molecules that Block Human p53 and CREB Binding Protein (…
2d82
monomer1081-1197
1×TTR;
Assess
Crystal Structure of the Bromodomain of human CREBBP in complex with a dihydroquinoxalinone ligand
4nyx
monomer1082-1197
1×2O4;
Assess
Crystal structure of the bromodomain of human CREBBP in complex with an isoxazolyl-benzimidazole li…
4nr7
monomer1082-1197
3×EDO; 1×2LO;
Assess
Crystal structure of CREBBP bromodomain complexed with FA26
5mpn
monomer1081-1196
2×YE5; 2×EDO;
Assess
Crystal structure of CREBBP bromodomain complexed with CBP015
5mqg
monomer1082-1197
1×F31;
Assess
Crystal structure of CREBBP bromodomain complexd with DR09
6fqu
monomer1082-1197
1×E3B;
Assess
Crystal Structure of the Bromodomain of human CREBBP in complex with a dihydroquinoxalinone ligand
4nyw
monomer1082-1197
1×SCN; 1×2O3; 2×EDO;
Assess
Bromodomain of CBP liganded with BMS-536924 and SGC-CBP30
7ugl
monomer1082-1197
1×N6I; 1×2LO;
Assess
Crystal structure of CREBBP bromodomain complexed with KD341
6sqe
monomer1082-1197
1×LSZ; 1×EDO;
Assess
Crystal structure of the bromodomain of human CREBBP bound to the inhibitor XDM1
5lpj
monomer1082-1197
1×XDM;
Assess
Crystal structure of the bromodomain of human CREBBP in complex with an oxazepin ligand
4nr6
monomer1082-1197
1×2LN;
Assess
CREBBP Bromodomain in complex with Cpd17 (N,2,7-trimethyl-2,3-dihydro-4H-benzo[b][1,4]oxazine-4-car…
5w0q
monomer1082-1197
3×SO4; 1×9UG;
Assess
Bromodomain of CBP liganded with BMS-536924 and CCS-1477
8fup
monomer1082-1197
1×N6I; 1×JHL; 2×EDO;
Assess
Crystal Structure of the Bromodomain of human CREBBP in complex with a quinazolin-one ligand
4nyv
monomer1081-1196
1×15E;
Assess
Bromodomain of CBP liganded with inhibitor iCBP5
8ga2
monomer1082-1197
1×EDO; 1×YVK;
Assess
Bromodomain of CBP liganded with CCS-1477
8fv2
monomer1082-1197
3×PO4; 1×JHL;
Assess
Bromodomain of CBP liganded with BMS-536924
7uge
monomer1082-1197
1×N6I;
Assess
Crystal structure of CREBBP bromodomain complexed with LB32A
6sqf
monomer1082-1197
1×LTW;
Assess
Structure of CREBBP bromodomain with compound 2 bound
6qst
monomer1082-1197
1×JGK;
Assess
Crystal structure of the bromodomain of human CREBBP bound to the benzodiazepinone G02778174
5i86
monomer1082-1196
1×EDO; 1×SCN; 1×69A;
Assess
Crystal structure of the bromodomain of human CREBBP bound to the benzodiazepinone G02857790
5i89
monomer1083-1197
1×ACT; 1×CA; 1×69B;
Assess
Crystal structure of CREBBP bromodomain complexed with UT07C
5mmg
monomer1083-1197
1×UT0;
Assess
Crystal structure of CREBBP bromodomain complexd with DT29
6fqo
monomer1083-1197
1×E2T; 1×EDO;
Assess
CREBBP bromodomain in complex with Cpd16 (5-(7-(difluoromethyl)-6-(1-methyl-1H-pyrazol-4-yl)-3,4-di…
6ay3
monomer1083-1197
1×C3J; 1×EDO; 1×NA;
Assess
CREBBP bromodomain in complex with Cpd17 (5-(7-(difluoromethyl)-6-(1-methyl-1H-pyrazol-4-yl)-3,4-di…
6ay5
monomer1083-1197
1×C3V; 2×SO4; 1×DMS; 1×GOL;
Assess
Crystal structure of CBP bromodomain liganded with CCS151
7xhe
monomer1083-1197
1×JHF; 1×EDO;
Assess
Bromodomain of CBP liganded with iCBP4
8fxa
monomer1083-1197
3×EDO; 1×YJY;
Assess
Crystal structure of CBP bromodomain liganded with UMB298 (compound 23)
7kpy
monomer1083-1197
1×EDO; 1×WU1;
Assess
Crystal structure of the human bromodomain of CREBBP bound to the inhibitor XDM4
5nrw
monomer1083-1197
1×96N; 4×EDO;
Assess
Crystal structure of CREBBP bromodomain complexd with US13A
5nlk
monomer1083-1197
1×92E;
Assess
BROMODOMAIN OF HUMAN CREBBP WITH N-(4-hydroxyphenyl)acetamide
4a9k
monomer1083-1197
2×EDO; 1×TYL; 1×SCN;
Assess
Crystal structure of the bromodomain of human CREBBP in complex with acetylated lysine
3p1c
monomer1083-1197
1×ALY; 1×SCN;
Assess
Crystal structure of the bromodomain of human CREBBP in complex with N-Methyl-2-pyrrolidone (NMP)
3p1d
monomer1083-1197
1×SCN; 1×MB3;
Assess
Selective pharmacological inhibition of the CREB binding protein bromodomain regulates inflammatory…
5cgp
monomer1083-1197
1×53W;
Assess
Crystal structure of the CREBBP bromodomain in complex with a benzo-diazepine ligand
6yim
monomer1084-1197
1×OS8;
Assess
Crystal structure of CREBBP bromodomain complexed with DSPB2A002
5owk
monomer1083-1196
2×7MX;
Assess
Crystal structure of the bromodomain of human CREBBP in complex with UP39
5eng
monomer1083-1196
1×5QN;
Assess
Crystal structure of the bromodomain of human CREBBP bound to the benzodiazepinone G02773986
5i83
monomer1083-1196
1×SCN; 1×68Y;
Assess
Crystal Structure of CBP bromodomain
4ouf
monomer1083-1196
1×PEG; 3×EDO;
Assess
CREBBP bromodomain in complex with Cpd19 (3-(7-(difluoromethyl)-6-(1-methyl-1H-pyrazol-4-yl)-3,4-di…
5w0e
monomer1083-1196
1×9U4;
Assess
Crystal structure of CREBBP bromodomain complexd with PB08
6fr0
monomer1084-1197
1×E3H;
Assess
CREBBP Bromodomain in complex with Cpd10 (1-(3-(7-(difluoromethyl)-6-(1-methyl-1H-pyrazol-4-yl)-3,4…
5w0l
monomer1083-1196
1×9UD;
Assess
CREBBP Bromodomain in complex with Cpd3 ((S)-1-(3-(6-(1-methyl-1H-pyrazol-4-yl)-3,4-dihydroquinolin…
5w0f
monomer1083-1196
1×9U7;
Assess
Crystal structure of CBP bromodomain liganded with CCS150
7xi0
monomer1083-1196
1×EL0; 1×GOL;
Assess
Crystal structure of CREBBP bromodomain complexed with CBP006
5mqe
monomer1083-1196
1×PKU;
Assess
Crystal structure of the CREBBP bromodomain in complex with a tetrahydroquinoxaline ligand
6yik
monomer1083-1196
2×OSQ;
Assess
Bromodomain of CBP liganded with iCBP8
8fxo
monomer1084-1197
1×YN5;
Assess
Bromodomain of CBP liganded with inhibitor iCBP2
8g6t
monomer1084-1197
1×YRI;
Assess
Crystal structure of CREBBP bromodomain complexd with DR46
6fqt
monomer1083-1196
2×AY2;
Assess
Crystal structure of CREBBP bromodomain complexed with LA36
6sqm
monomer1084-1197
1×LU5;
Assess
Crystal structure of the bromodomain of human CREBBP in complex with dimethyl sulfoxide (DMSO)
3p1e
monomer1083-1196
1×SCN; 1×DMS;
Assess
Crystal structure of the CBP bromodomain in complex with CPI703
5dbm
monomer1083-1196
1×58N;
Assess
Crystal Structure of the Bromodomain of Human CREBBP
3dwy
monomer1084-1197
3×EDO;
Assess
Bromodomain of CBP liganded with iCBP7
8fxn
monomer1084-1197
1×YN0; 2×EDO;
Assess
Crystal structure of the CREBBP bromodomain in complex with a tetrahydroquinoxaline ligand
6yil
monomer1085-1197
1×OSQ;
Assess
Crystal structure of the bromodomain of human CREBBP in complex with AYC
5eic
monomer1084-1196
2×EDO;
Assess
Crystal structure of the CBP bromodomain in complex with CPI098
4yk0
monomer1084-1196
1×986; 1×EDO;
Assess
Crystal structure of the bromodomain of human CREBBP in complex with an isoxazolyl-benzimidazole li…
4nr5
monomer1083-1195
1×2LL; 1×NO3; 1×EDO;
Assess
A multiconformer ligand model of an isoxazolyl-benzimidazole ligand bound to the bromodomain of hum…
6dmk
monomer1083-1195
1×NO3; 1×2LL; 1×EDO;
Assess
Crystal structure of the bromodomain of human CREBBP in complex with an isoxazolyl-benzimidazole li…
4nr4
monomer1085-1197
1×2LK; 1×EDO;
Assess
Crystal structure of the bromodomain of human CREBBP in complex with ACA007
6sxx
monomer1084-1196
2×EDO; 1×LXQ;
Assess
CBP bromodomain complexed with YF2-23
7juo
monomer1084-1196
1×YF2;
Assess
Crystal Structure of the CBP in complex with the Y08188
7xm7
monomer1084-1196
1×GAY; 1×GOL;
Assess
CREBBP bromodomain in complex with Cpd 44 (3-((5-acetyl-1-(cyclopropylmethyl)-4,5,6,7-tetrahydro-1H…
5ktw
monomer1085-1196
1×6XG; 3×EDO;
Assess
CREBBP bromodomain in complex with Cpd59 ((S)-1-(3-((2-fluoro-4-(1-methyl-1H-pyrazol-4-yl)phenyl)am…
5ktx
monomer1085-1196
1×6XH; 2×EDO; 1×DMS;
Assess
CREBBP bromodomain in complex with Cpd6 (methyl 1H-indole-3-carboxylate)
6axq
monomer1085-1196
2×DMS; 1×C2Y;
Assess
CREBBP bromodomain in complex with Cpd 4 (1-(1-(cyclopropylmethyl)-3-(1H-indol-4-yl)-1,4,6,7-tetrah…
6alc
monomer1085-1196
1×DMS; 1×EDO;
Assess
Crystal structure of the bromodomain of human CREBBP in complex with UL04
4tqn
monomer1084-1195
1×UL4; 3×EDO;
Assess
Crystal structure of CBP bromodomain liganded with CCS1477
7xh6
monomer1085-1196
1×GOL; 1×DMS; 1×JHL;
Assess
Crystal structure of CREBBP bromodomain complexed with DK19
5mpk
monomer1084-1195
1×0BC;
Assess
Crystal structure of the bromodomain of human CREBBP in complex with XZ08
4ts8
monomer1085-1196
2×EDO; 1×XZ8;
Assess
Crystal structure of CBP bromodomain liganded with 9c
7evj
monomer1081-1191
1×JE9; 1×PO4; 1×GOL;
Assess
Crystal structure of CREBBP bromodomain complexed with CBP007
5mpz
monomer1084-1193
2×4I8;
Assess
Crystal structure of the bromodomain of human CREBBP bound to pyrazolopiperidine scaffold
5ktu
monomer1089-1195
1×6XB;
Assess
Non-native Solution Structure of a fragment of the CH1 domain of CBP
1liq
monomer376-402
1×ZN;
Assess
Solution structure of Designed Functional Finger 2 (DFF2): Designed mutant based on non-native CHAN…
1wo5
monomer376-400
1×ZN;
Assess
Solution structure of Designed Functional Finger 5 (DFF5): Designed mutant based on non-native CHAN…
1wo6
monomer376-400
1×ZN;
Assess
Solution structure of Designed Functional Finger 7 (DFF7): Designed mutant based on non-native CHAN…
1wo7
monomer376-400
1×ZN;
Assess
Solution structure of Minimal Mutant 1 (MM1): Multiple alanine mutant of non-native CHANCE domain
1wo3
monomer376-400
1×ZN;
Assess
Solution structure of Minimal Mutant 2 (MM2): Multiple alanine mutant of non-native CHANCE domain
1wo4
monomer376-400
1×ZN;
Assess

6 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
6fgs.1.Amonomer0.62347-440
1×ZN;31.40
Assess
6gyr.2.Amonomer0.611082-1701
3×ZN;87.05
Assess
1p4q.1.Bmonomer0.61344-439
3×ZN;93.75
Assess
8han.1.Imonomer0.601088-1700
100.00
Assess
8haj.1.Kmonomer0.591086-1701
88.70
Assess
6dmx.1.Cmonomer0.54592-672
100.00
Assess

6 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 22ka4.1.Amonomer0.68342-423
1×ZN;79.27
Assess
Isoform 26gyr.2.Amonomer0.611044-1663
3×ZN;87.05
Assess
Isoform 28han.1.Imonomer0.601050-1662
100.00
Assess
Isoform 28haj.1.Kmonomer0.601048-1663
88.70
Assess
Isoform 26dmx.1.Cmonomer0.52554-634
100.00
Assess
Isoform 26fgn.1.Amonomer0.51346-456
1×ZN;20.39
Assess